CUDC-427
CAS: 1446182-94-0
Ref. 3D-WHC18294
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Product Information
CUDC-427 is a small molecule drug that selectively inhibits the growth of tumor cells by inducing apoptosis. It has shown efficacy in preclinical studies for the treatment of adrenocortical carcinoma, fibrolamellar carcinoma, and skin cancer. CUDC-427 has been shown to have predictive biomarker properties and clinical relevance as an effective anti-cancer agent. This drug has also been shown to have toxicities in preclinical studies, which may limit its therapeutic use.
Chemical properties
Technical inquiry about: 3D-WHC18294 CUDC-427
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.